[KongchangAI]
Unverified50% confidenceFactExact time

The study validated the method in two clinical scenarios: joint BRAF+/MSI+ prediction in colorectal cancer and joint EGFR+/TP53+ prediction in lung adenocarcinoma.

1
Sources
50%
Confidence
Long-term
Relevance
10/7/2026
First Seen

Sources

Related Entities

Related Claims

Cite This Claim

Stable URI
https://kongchang.com/claim/983420
API
curl https://kongchang.com/api/v1/knowledge/claims/983420
MCP
get_claim(id=983420)